Dr. Jeffrey J. Siracuse, M.D.
Vascular Surgery (Vascular Surgery Physician)
- Medicare participating
At a glance
- Medical school
- New York Medical College (2005)
- Years since graduation
- 21
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 311
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Medical school: New York Medical College
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular Surgery Physician primary
MA license 233724 -
Surgery Physician
MA license 233724
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boston Medical Center Boston, MA
- Good Samaritan Medical Center Brockton, MA
Medical groups
- Bmc Affiliated Physicians, Inc. (564 clinicians)
- Boston University General Surgical Associates, Inc. (84 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 311
- Services billed
- 521
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 95 | 63 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 62 | 60 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 50 | 48 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 45 | 42 |
| Ultrasound of both sides of head and neck blood flow | 39 | 39 |
| Complete ultrasound study of arm and leg arteries | 29 | 29 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 29 | 19 |
| New patient office or other outpatient visit, 30-44 minutes | 14 | 14 |
| Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 5 companies reported 10 payments worth $857 in total to this clinician.
| W. L. Gore & Associates, Inc. | $304 |
|---|---|
| Penumbra, Inc. | $272 |
| Endologix LLC | $151 |
| Cook Medical LLC | $114 |
| Medtronic, Inc. | $16.05 |
| Food and Beverage | $857 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $56,056 in research payments for these studies, mostly to the institutions running them.
- To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
Humacyte Global, Inc. · Active, not recruiting · NCT05908084 - AGILITY BDPI-20-010
Bard Peripheral Vascular, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.